TearLab Corporation to Release Q1 2014 Financial Results on May 8, 2014
16 April 2014 - 10:30PM
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) expects to announce its
Q1 2014 financial results after market closes on Thursday May 8,
2014. TearLab is pleased to invite all willing participants in a
conference call during which time financial results will be
discussed. That call will be held at 4:30pm Eastern at 877-303-1593
Date: May 8, 2014
Time: 4:30 PM ET
Listen via Internet: http://www.tearlab.com/investor/
Schedule this webcast into MS-Outlook calendar (click open when
prompted):
http://apps.shareholder.com/PNWOutlook/t.aspx?m=64224&k=96C4B534
Telephone: 877-303-1593
For those willing to listen to a recording of the call via
telephone, a replay will be made available by 7:30pm Eastern after
the conclusion of the live call and will remain posted until
11:59pm Eastern on May 14, 2014. To listen to the recording, simply
telephone 855-859-2056 (toll free) or 404-537-3406 and enter
conference ID 32020994 when prompted.
About TearLab Corporation
TearLab Corporation (www.tearlab.com) develops and
commercializes lab-on-a-chip technologies that enable eye care
practitioners to improve standard of care by objectively and
quantitatively testing for disease markers in tears at the
point-of-care. The TearLab(r) Osmolarity Test, that enables eye
care practitioners to test for highly sensitive and specific
biomarkers using nanoliters of tear film at the point-of-care, is
the first assay developed for the award winning TearLab Osmolarity
System. Headquartered in San Diego, CA, TearLab Corporation's
common shares trade on the NASDAQ Capital Market under the symbol
'TEAR' and on the Toronto Stock Exchange under the symbol
'TLB'.
Forward-Looking Statements
This press release may contain forward-looking statements. These
statements relate to future events and are subject to risks,
uncertainties and assumptions about TearLab. Examples of
forward-looking statements in this press release include statements
regarding the future potential of the TearLab Osmolarity System and
the related impact on our sales. These statements are only
predictions based on our current expectations and projections about
future events. You should not place undue reliance on these
statements. Actual events or results may differ materially. Many
factors may cause our actual results to differ materially from any
forward-looking statement, including the factors detailed in our
filings with the Securities and Exchange Commission and Canadian
securities regulatory authorities, including but not limited to our
annual and quarterly reports on Forms 10-K and 10-Q. We do not
undertake to update any forward-looking statements.
CONTACT: Kilmer Lucas Inc.
Stephen Kilmer (President)
905 690-2400 Ext.21
stephen@kilmerlucas.com
Talbots (NYSE:TLB)
Historical Stock Chart
Von Nov 2024 bis Dez 2024
Talbots (NYSE:TLB)
Historical Stock Chart
Von Dez 2023 bis Dez 2024
Echtzeit-Nachrichten über Talbots (The) (New York Börse): 0 Nachrichtenartikel
Weitere News-Artikel